Study Examines Factors For Medication-Induced Parkinsonism For Patients With Schizophrenia

HCPlive (3/25, Walter) reported, “Several risk factors for drug-induced parkinsonism” (DIP) have “emerged for patients with schizophrenia, including age and cognition status,” according to a “cross-sectional analysis of a multicenter, observational, real-world, prospective cohort” that “examined 969 patients with a baseline assessment between 2012-2018 from four mental health centers in Shanghai.” The findings were published online March 3 in the journal Frontiers in Pharmacology.
“ From this study, we learned that age, treatment with high D2 receptor antagonistic antipsychotics, and the valproate dose are the main risk factors for DIP. DIP was significantly correlated with psychiatric symptoms and social dysfunction in Chinese schizophrenia patients. ”

Related Links:

— “Investigators Identify Risk Factors for Drug-Induced Parkinsonism for Schizophrenia Patients “Kenny Walter, HCPlive, March 25, 2023

Posted in In The News.